Home Page
Sunlight Ultrasound Technologies and Emory University Join Forces to Study a New Breakthrough Technology for the Diagnosis of Osteoporosis
Atlanta, Georgia (February 9, 1999) - Residents in the Atlanta area are to participate in bone strength testing to assess their risk for osteoporosis and osteoporotic fracture. The new program, a joint project of Sunlight Ultrasound Technologies and Emory Clinic, Emory University, Atlanta, GA, will be free of charge to qualified candidates. Heading the project will be Nelson B. Watts, MD, FACE, and director of the Osteoporosis Program at Emory University.

The Atlanta study calls for the collection and evaluation of bone strength measurement result from 110 subjects. The data will then be analyzed to determine reference curves and average peak bone strength as part of an overall geographic bone strength study for the North American population. Participants' bone strength will be evaluated by Sunlight Omnisense™ 7000S, a new patented device designed for the diagnosis and monitoring of osteoporosis.

Osteoporosis is a global epidemic responsible for more than 1.5 million fractures annually. The annual cost of treating osteoporosis is estimated at $15 billion in the United States alone. A woman's risk of an osteoporotic hip fracture is equal to her combined risk of breast, uterine, and ovarian cancer.

"With the recent advances in new treatment therapies, there has been a tremendous demand to develop accurate diagnostic devices that can help diagnose as well as monitor osteoporosis," said Dr. Chen Barir, CEO and chairman at Sunlight Ultrasound Technologies. Omnisense 7000S has proven itself both in research and worldwide clinical trials, like the Atlanta study, to be an exceptionally accurate and precise tool." "In contrast to other diagnostic devices for osteoporosis that measure bone density by directing X-ray beams or ultrasound waves into or through the bone," explained Dr. Irit Yaniv, Medical Director at Sunlight, "Omnisense provides a more accurate diagnosis by measuring along-the-bone, eliminating discrepancies caused by soft tissue effects." Omnisense assesses overall bone strength by taking into account several bone properties such as mineral density, elasticity, cohesiveness, and micro-architecture.